Equity markets in the Asia-Pacific region (APR) finished trading in the green zone on Tuesday after the rise in the US markets a day earlier, trading data showed.
As a result of trading, the Shanghai Composite Index rose 0.8%, to 3446.73 points, the Shenzhen Stock Exchange Shenzhen Composite - 1.1%, to 2196.51 points, the Hong Kong Hang Seng Index - 0.7% , up to 29027.69 points. South Korean KOSPI added 0.7% to 3067.17 points. The Australian S & P / ASX 200 indexes rose 0.8% to 6827.1 points. Japan's Nikkei 225 rose 0.52% to 29921.09 points.
Traders in Asia drew attention to the fact that US exchanges rose by the end of trading on Monday - up to 1% on major indices. Markets are waiting for the next meeting of the US Federal Reserve System (FRS); on March 16-17 - it is expected that following its results the regulator will keep the base interest rate at the level of 0-0.25% per annum, and also leave the volume of the asset repurchase program unchanged.
"The rise in US equity markets has largely helped bolster market sentiment. But many investors have refrained from active buying, awaiting the results of the US Federal Reserve meeting. Sentiment remains unchanged, but players are still nervous about US interest rates," Sr. told Agence France Presse. Chibagin Asset Management Manager Yoshihiro Okumura.
At the same time, traders continue to monitor the coronavirus vaccination situation. So, Japanese Prime Minister Yoshihide Suga said that the decision on the vaccine company AstraZeneca, the use of which was suspended in a number of countries, will be made after collecting and analyzing information.
Japan has signed a contract with AstraZeneca to supply 120 million doses to 60 million people. The AstraZeneca vaccine is approved by the European drug regulator EMA for use in the European Union, but a number of EU countries have suspended its use due to possible adverse reactions.